Apnea Monitors for Infants
Customize your policy alerts
Sign up for Aetna Policy 0003 alerts
Get alerted when Policy 0003 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, coverage, coding, and investigational indications for apnea monitors for infants, and specifies clinical criteria and duration of coverage for Aetna members.
No material clinical or coverage changes in this revision.
Coverage Criteria for Infant Apnea Monitors
Medical Necessity Indications
Covered when ANY of the following infant-specific clinical indications are present (infants < 12 months unless otherwise specified):
ALTE defined as combination of apnea, color change, marked change in muscle tone, choking, or gagging.
Post‑conceptional age = gestational age at birth plus age in weeks from birth.
Experimental / Investigational
Not covered — considered experimental/investigational:
Continued use of a smart monitor for the purpose of obtaining ongoing pneumograms or sleep studies is not considered medically necessary. If the ordering clinician wishes to continue obtaining pneumograms while the child is on a smart monitor, Aetna will alert the ordering clinician that continued use of the smart monitor for that purpose is not medically necessary. A regular (non-smart) apnea monitor may be considered medically necessary for the duration the clinician requests ongoing studies as specified in the policy.
This Clinical Policy Bulletin is developed to assist in administering plan benefits and is not a contract and does not constitute an offer of coverage. Coverage for a member is governed by the terms of the member's plan or program benefits; the bulletin provides a general description and does not guarantee coverage.
Apnea monitors used for indications other than those explicitly listed in the medical necessity section of this policy are considered experimental/investigational because their effectiveness for other indications has not been established and are therefore not medically necessary. The remote infrared sensor method for detection of infant sleep apnea is specifically listed as investigational.
Coding and Clinical Thresholds
| 94774 | Pediatric home apnea monitoring event recording including respiratory rate, pattern and heart rate per 30-day period of time; includes monitor attachment, download of data, physician review, interpretation, and preparation of a report. |
| 94775 | Monitor attachment only (includes hook-up, initiation of recording and disconnection). |
| 94776 | Monitoring, download of information, receipt of transmission(s) and analyses by computer only. |
| 94777 | Physician review, interpretation and preparation of report only. |
| A37.00 - A37.91 | Whooping cough. |
| G70.2 | Congenital and developmental myasthenia. |
| G93.1 | Anoxic brain damage, not elsewhere classified. |
| I49.5 | Sick sinus syndrome. |
| I49.8 | Other specified cardiac arrhythmias. |
| K21.9 | Gastro-esophageal reflux disease without esophagitis. |
| P07.00 - P07.18 P07.21 - P07.39 | Disorders of newborn related to short gestation and low birthweight, not elsewhere classified. |
| P22.0 - P28.89 | Respiratory disorders specific to the perinatal period. |
| P29.12 | Neonatal bradycardia. |
| P84 | Other problems with newborn. |
Provider Actions, Documentation, and Billing Notes
Smart monitor and ongoing studies
Use of smart monitors and continuation of pneumograms: Because smart monitors can record and transmit detailed data, continued sleep studies and pneumograms are not typically necessary when a smart monitor is used. If the ordering physician requests ongoing pneumograms despite use of a smart monitor, the plan will notify the ordering physician that continued use of a smart monitor for that purpose is not considered medically necessary. Aetna considers a regular (non‑smart) apnea monitor medically necessary for the duration the physician determines ongoing studies are required.
- Smart monitors — continued pneumograms generally not medically necessary
- Regular apnea monitor — may be considered medically necessary if physician continues to request ongoing studies
Clinical Policy Bulletin is informational
Informational nature of the Clinical Policy Bulletin: This Clinical Policy Bulletin is provided to assist in administering plan benefits and to summarize medical‑necessity criteria. It is informational only and does not itself guarantee coverage, authorize payment, or substitute for the independent medical judgment of treating providers. Participating providers remain independent practitioners and are responsible for the medical advice and treatment of members.
- Clinical Policy Bulletin is informational — not a guarantee of coverage or payment
- Treating providers retain responsibility for clinical decisions
Documentation for continuation beyond 12 months
Documentation to support continuation of monitoring beyond 12 months: For children older than 12 months, continued apnea monitoring requires physician documentation that justifies ongoing monitoring (for example: persistent alarms, documented recurrent apnea, bradycardia, or hemoglobin/oxygen desaturation). When the policy lists a specified medically necessary duration that extends past 12 months, coverage may continue for that specified duration if adequately documented by the physician.
- Physician documentation required for monitoring beyond 12 months (e.g., ongoing alarms, documented events, desaturations)
- Specified medically necessary durations that extend past 12 months remain covered if supported by documentation
Clinical Policy Bulletins contain a part and provider responsibilities
Role and limits of Clinical Policy Bulletins and provider responsibilities: Clinical Policy Bulletins summarize Aetna coverage positions and contain medical‑necessity criteria, coding guidance, and related notes. They do not replace provider clinical judgment, do not themselves authorize services, and do not guarantee coverage. Treating providers are responsible for submitting appropriate documentation (clinical records, testing results, and justification for continued monitoring) to support coverage decisions and any prior authorization requests determined by the plan.
- CPBs contain medical‑necessity criteria, coding guidance, and billing notes
- CPBs are not coverage guarantees or authorizations
- Providers must submit clinical documentation and supporting records for coverage review or prior authorization
Background
Infant apnea may be central (no respiratory effort), obstructive (chest movement without airflow), or mixed (features of both in the same event). Home apnea monitors typically detect chest movement and heart rate and are configured to alarm for common thresholds such as apnea ≥ 20 seconds, heart rate < 80 beats per minute, or oxygen desaturation events. Contactless remote infrared sensor methods have been investigated but are considered experimental and their effectiveness has not been established.
Definitions
Revision History
Policy became effective.
Policy underwent last review.
Next scheduled review date.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.